Rosetta Genomics Signs on PPO MultiPlan for Coverage of Cancer Dx | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics today announced the execution of an agreement with preferred provider organization MultiPlan for Rosetta's products, including the Rosetta Cancer Origin Test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.